Paper39337387
O-GlcNAcylation: Crosstalk between Hemostasis, Inflammation, and Cancer.
Vásquez Martínez IP and 9 others. Int J Mol Sci, 2024. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. O-GlcNAcylation: Crosstalk between Hemostasis, Inflammation, and Cancer. Papers, record 39337387. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39337387
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Inflammation | Major topic |
| Hemostasis | Major topic |
| Acetylglucosamine | Major topic |
| Signal Transduction | Major topic |
| Humans | |
| Animals | |
| Protein Processing, Post-Translational | |
| Glycosylation |
Source PubMed
References221
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28681591 | O-GlcNAcylation of NF-κB Promotes Lung Metastasis of Cervical Cancer Cells via Upregulation of CXCR4 Expression. | Mol Cells | 2017 | https://conductscience.org/library/papers/28681591 | PubMed |
| 2 | 19050704 | Expression of uPAR mRNA in peripheral blood is a favourite marker for metastasis in gastric cancer cases. | Br J Cancer | 2009 | https://conductscience.org/library/papers/19050704 | PubMed |
| 3 | 36410399 | Hypercoagulability and Thrombosis Risk in Prostate Cancer: The Role of Thromboelastography. | Semin Thromb Hemost | 2023 | https://conductscience.org/library/papers/36410399 | PubMed |
| 4 | 11336633 | The potential mechanism of the diabetogenic action of streptozotocin: inhibition of pancreatic beta-cell O-GlcNAc-selective N-acetyl-beta-D-glucosaminidase. | Biochem J | 2001 | https://conductscience.org/library/papers/11336633 | PubMed |
| 5 | 11875705 | Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer. | Br J Cancer | 2002 | https://conductscience.org/library/papers/11875705 | PubMed |
| 6 | 31974291 | O-GlcNAc Transferase Regulates Cancer Stem-like Potential of Breast Cancer Cells. | Mol Cancer Res | 2020 | https://conductscience.org/library/papers/31974291 | PubMed |
| 7 | 36010605 | The Interaction of Human Papillomavirus Infection and Prostaglandin E2 Signaling in Carcinogenesis: A Focus on Cervical Cancer Therapeutics. | Cells | 2022 | https://conductscience.org/library/papers/36010605 | PubMed |
| 8 | 34019948 | O-GlcNAc modification regulates MTA1 transcriptional activity during breast cancer cell genotoxic adaptation. | Biochim Biophys Acta Gen Subj | 2021 | https://conductscience.org/library/papers/34019948 | PubMed |
| 9 | 34671213 | Enolase 1, a Moonlighting Protein, as a Potential Target for Cancer Treatment. | Int J Biol Sci | 2021 | https://conductscience.org/library/papers/34671213 | PubMed |
| 10 | 35164874 | Urinary bladder Schistosoma haematobium-related squamous cell carcinoma: a report of two fatal cases and literature review. | Trop Dis Travel Med Vaccines | 2022 | https://conductscience.org/library/papers/35164874 | PubMed |
| 11 | 24865644 | O-GlcNAcylation is increased in prostate cancer tissues and enhances malignancy of prostate cancer cells. | Mol Med Rep | 2014 | https://conductscience.org/library/papers/24865644 | PubMed |
| 12 | 38421488 | The pathogenesis of cancer-associated thrombosis. | Int J Hematol | 2024 | https://conductscience.org/library/papers/38421488 | PubMed |
| 13 | 33932560 | Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting. | Biochim Biophys Acta Rev Cancer | 2021 | https://conductscience.org/library/papers/33932560 | PubMed |
| 14 | 30159314 | Understanding Urogenital Schistosomiasis-Related Bladder Cancer: An Update. | Front Med (Lausanne) | 2018 | https://conductscience.org/library/papers/30159314 | PubMed |
| 15 | 34302904 | O-GlcNAcylation: Implications in normal and malignant hematopoiesis. | Exp Hematol | 2021 | https://conductscience.org/library/papers/34302904 | PubMed |
| 16 | 36104770 | O-GlcNAcylation: an important post-translational modification and a potential therapeutic target for cancer therapy. | Mol Med | 2022 | https://conductscience.org/library/papers/36104770 | PubMed |
| 17 | 25070012 | Neutrophil extracellular traps in cancer progression. | Cell Mol Life Sci | 2014 | https://conductscience.org/library/papers/25070012 | PubMed |
| 18 | 16799348 | Increased lactate levels impair the coagulation system--a potential contributing factor to progressive hemorrhage after traumatic brain injury. | J Neurosurg Anesthesiol | 2006 | https://conductscience.org/library/papers/16799348 | PubMed |
| 19 | 28212582 | The association of pretreatment thrombocytosis with prognosis and clinicopathological significance in cervical cancer: a systematic review and meta-analysis. | Oncotarget | 2017 | https://conductscience.org/library/papers/28212582 | PubMed |
| 20 | 30952976 | O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes. | Sci Rep | 2019 | https://conductscience.org/library/papers/30952976 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42153620 | Systematic Quantification of Protein O-GlcNAcylation Reveals Common and Cell-Type-Specific Responses to N-Glycosylation Inhibition in Human Cells. | Anal Chem | 2026 | https://conductscience.org/library/papers/42153620 | PubMed |
| 41546072 | OGT-mediated O-GlcNAcylation of MAGI1 exacerbates high glucose-triggered inflammation and dedifferentiation of vascular smooth muscle cells by activating the PI3K/AKT pathway. | Hereditas | 2026 | https://conductscience.org/library/papers/41546072 | PubMed |
| 41466540 | Dammarenediol II enhances etoposide-induced apoptosis by targeting O-GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer. | Mol Oncol | 2026 | https://conductscience.org/library/papers/41466540 | PubMed |
| 41376630 | Inflammatory factors collaboratively link Helicobacter pylori-induced gastritis to gastric cancer. | Front Immunol | 2025 | https://conductscience.org/library/papers/41376630 | PubMed |
| 40824482 | Cell cycle regulation in cancer cells by O-GlcNAcylation. | Glycoconj J | 2025 | https://conductscience.org/library/papers/40824482 | PubMed |
| 40820328 | Machine Learning-Based Integration of Single-Cell and Bulk Transcriptome Reveals Coagulation Signature and Phenotypic Heterogeneity in Hepatocellular Carcinoma. | IET Syst Biol | 2025 | https://conductscience.org/library/papers/40820328 | PubMed |
| 39616984 | O-GlcNAcylation in ovarian tumorigenesis and its therapeutic implications. | Transl Oncol | 2025 | https://conductscience.org/library/papers/39616984 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| MTOR | 2475 | PubTator's text mining | https://conductscience.org/library/genes/2475 | NCBI Gene |
| MYC | 4609 | PubTator's text mining | https://conductscience.org/library/genes/4609 | NCBI Gene |
| OGT | 8473 | PubTator's text mining | https://conductscience.org/library/genes/8473 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39337387
GET https://conductscience.org/api/papers/v1/39337387/references?page=2